Prostate Cancer Canada is the only national foundation dedicated to the elimination of the disease through research, education support and awareness.
Prostate cancer is the most common cancer to affect Canadian men. PCC recommends that men get a PSA test in their 40's to establish their baseline.
Prostate Cancer Canada is pleased be contributing to innovative advancements in prostate cancer research.
Just found out you have prostate cancer? Looking for information? Wondering what programs and resources are available to you? Help is here.
Enter for your chance to WIN a Corvette Stingray 2LT! Generously donated by TADA, 100% of the proceeds will be directed to prostate cancer research.
You can help Canadian men and their families dealing with prostate cancer by making a donation today.
Understanding prostate cancer may seem overwhelming at first. In this section, we will explain the basics: the who, what, where, when and why of prostate cancer.
This section provides information about tests that are used for early detection and diagnosis. It also covers tests that are used to find out what type of prostate cancer is present and how far the cancer has spread.
Vienna, Austria: A new genetic “signature” to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna will hear today (Saturday). More
Toronto, ON – March 10, 2014 – There is no disputing a cancer diagnosis is among the worst news a person or their family could receive. More
Toronto, ON – February 12, 2014 – Prostate Cancer Canada (PCC) is proud to announce the recipients of its 2014 Movember Rising Star awards in prostate cancer research. More
Toronto, ON - January 28, 2014 – We are pleased to announce a partnership between Prostate Cancer Canada and the Canadian Cancer Society in launching the Prostate Cancer Information Service (PCIS), which provides support to anyone affected by prostate cancer. More